{"symbol":"MDT","fiscalQuarter":"Q4-2026","reportDate":"2026-06-03","reportTime":"BMO","status":"upcoming","company":{"name":"Medtronic plc","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/MDT/earnings/Q4-2026","estimates":{"consensusEps":1.5465,"consensusRevenue":9614.54,"epsLow":1.52,"epsHigh":1.66,"whisperEps":null,"numAnalysts":null},"preBrief":{"companySnapshot":"Medtronic plc (MDT) is a global leader in medical technology, providing innovative healthcare solutions across various segments. With a market cap of $116 billion, the company plays a crucial role in the health care equipment sector, focusing on improving patient outcomes through advanced medical devices and therapies.","keyMetrics":[{"name":"EPS","why":"Earnings per share is a key indicator of profitability and is closely watched by investors.","consensus":"$1.55"},{"name":"Revenue","why":"Total revenue provides insight into the company's sales performance and market demand.","consensus":"$9.6B"}],"lastQuarterRecap":{"summary":"In Q3-2026, Medtronic reported an EPS of $1.36, beating estimates slightly. However, the stock declined by 3.10% the following day, reflecting market caution.","promises":[]},"wallStreetExpectations":{"summary":"Analysts expect Medtronic to deliver a solid quarter with an EPS of $1.55 and revenue of $9.6 billion. However, recent stock performance has been mixed, leading to cautious sentiment.","bullCase":"If Medtronic can exceed EPS estimates and show strong revenue growth, it may signal a recovery in demand for its products, boosting investor confidence.","bearCase":"Conversely, if the company misses earnings expectations or provides weak guidance, it could lead to further declines in stock price, reflecting ongoing challenges in the healthcare market."},"optionsSignal":{"impliedMove":"5.32%","context":"The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement."},"earningsTrackRecord":[{"quarter":"Q3-2026","epsSurprise":"+2.10%","reaction":"-3.10%"},{"quarter":"Q2-2026","epsSurprise":"+3.66%","reaction":"+4.69%"},{"quarter":"Q1-2026","epsSurprise":"-4.26%","reaction":"-3.14%"},{"quarter":"Q4-2025","epsSurprise":"+2.73%","reaction":"-2.27%"},{"quarter":"Q3-2025","epsSurprise":"+2.43%","reaction":"-7.26%"},{"quarter":"Q2-2025","epsSurprise":"+1.20%","reaction":"-2.96%"},{"quarter":"Q1-2025","epsSurprise":"+2.76%","reaction":"+0.66%"},{"quarter":"Q4-2024","epsSurprise":"+0.76%","reaction":"-5.11%"}],"pivotalQuestions":[{"question":"Will Medtronic's EPS exceed the consensus estimate of $1.55?","whyItMatters":"A beat on EPS could signal stronger-than-expected demand and operational efficiency, which would be well-received by the market."},{"question":"What guidance will management provide regarding future revenue growth?","whyItMatters":"Investors will be looking for insights into the company's outlook, especially in light of recent mixed performance."}],"thesisBreakLevels":{"bullTrigger":"An EPS of $1.60 or higher would confirm the bull case, indicating strong operational performance.","bearTrigger":"An EPS below $1.52 would confirm the bear case, suggesting ongoing challenges in the business.","context":"This quarter's performance is critical as it follows a pattern of mixed results, and investors are keen to see if Medtronic can regain momentum."},"scenarioPlaybook":{"beatAndRaise":"If Medtronic beats expectations, history suggests the stock could rise by approximately 2.19% on the first day, confirming a positive outlook.","inLineCautious":"If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.","miss":"A miss could lead to a decline of around 3.14%, reflecting investor disappointment and potential concerns about future growth."},"whatTheStreetIsMissing":{"thesis":"The Street may be underestimating the potential for Medtronic to exceed EPS expectations due to recent operational improvements not fully reflected in analyst models.","supportingPoints":["The company's recent history shows an 88% EPS beat rate, indicating a strong track record of outperforming estimates.","Options pricing suggests a higher expected move than historical averages, indicating that investors anticipate significant news.","Recent insider selling could suggest a cautious approach, but it may not reflect the broader operational outlook."],"riskToConsensus":"If revenue growth exceeds $9.7 billion, it could challenge the current cautious sentiment and lead to upward revisions in estimates."},"whatToListenFor":["Any updates on new product launches and their expected impact on sales.","Management's commentary on market conditions and competitive landscape.","Insights into cost management strategies and their effect on margins.","Details on geographic performance, especially in emerging markets.","Any changes to guidance based on recent operational performance."],"metaDescription":"Medtronic (MDT) reports Q4 2026 earnings June 3. Analysts expect $1.55 EPS on $9.6B revenue. Here's what to watch."}}